Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma (Nature Communications, (2020), 11, 1, (6262), 10.1038/s41467-020-19810-w)

Antoni Ribas; Alain Algazi; Paolo A. Ascierto; Marcus O. Butler; Sunandana Chandra; Michael Gordon; Leonel Hernandez-Aya; Donald Lawrence; Jose Lutzky; Wilson H. Miller; Katie M. Campbell; Bruno Delafont; Shannon Marshall; Nancy Mueller; Caroline Robert

doi:10.1038/s41467-021-25285-0

Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma (Nature Communications, (2020), 11, 1, (6262), 10.1038/s41467-020-19810-w)

Antoni Ribas^*, Alain Algazi, Paolo A. Ascierto, Marcus O. Butler, Sunandana Chandra, Michael Gordon, Leonel Hernandez-Aya, Donald Lawrence, Jose Lutzky, Wilson H. Miller, Katie M. Campbell, Bruno Delafont, Shannon Marshall, Nancy Mueller, Caroline Robert

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Abstract

There was an error in the original version of this Article. A table describing the patient characteristics and the sample collection was not included in the paper. This table is now included as Supplementary Data 1 and the first sentence of the Results section has been amended to state ‘Between December 2013 and April 2015, 99 patients were screened. Sixty-eight patients were enrolled from 11 study centers (Supplementary Fig. 1, Supplementary Data 1), with 31 patients subsequently excluded due to screening failures’. The PDF and HTML versions of the Article have been updated.

Original language	English (US)
Article number	5022
Journal	Nature communications
Volume	12
Issue number	1
DOIs	https://doi.org/10.1038/s41467-021-25285-0
State	Published - Dec 1 2021

ASJC Scopus subject areas

General Chemistry
General Biochemistry, Genetics and Molecular Biology
General Physics and Astronomy

Access to Document

10.1038/s41467-021-25285-0

Cite this

Ribas, A., Algazi, A., Ascierto, P. A., Butler, M. O., Chandra, S., Gordon, M., Hernandez-Aya, L., Lawrence, D., Lutzky, J., Miller, W. H., Campbell, K. M., Delafont, B., Marshall, S., Mueller, N., & Robert, C. (2021). Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma (Nature Communications, (2020), 11, 1, (6262), 10.1038/s41467-020-19810-w). Nature communications, 12(1), Article 5022. https://doi.org/10.1038/s41467-021-25285-0

@article{887dfc9b6ace45adabf2c3690aa34f9c,

title = "Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma (Nature Communications, (2020), 11, 1, (6262), 10.1038/s41467-020-19810-w)",

abstract = "There was an error in the original version of this Article. A table describing the patient characteristics and the sample collection was not included in the paper. This table is now included as Supplementary Data 1 and the first sentence of the Results section has been amended to state {\textquoteleft}Between December 2013 and April 2015, 99 patients were screened. Sixty-eight patients were enrolled from 11 study centers (Supplementary Fig. 1, Supplementary Data 1), with 31 patients subsequently excluded due to screening failures{\textquoteright}. The PDF and HTML versions of the Article have been updated.",

author = "Antoni Ribas and Alain Algazi and Ascierto, {Paolo A.} and Butler, {Marcus O.} and Sunandana Chandra and Michael Gordon and Leonel Hernandez-Aya and Donald Lawrence and Jose Lutzky and Miller, {Wilson H.} and Campbell, {Katie M.} and Bruno Delafont and Shannon Marshall and Nancy Mueller and Caroline Robert",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2021.",

year = "2021",

month = dec,

day = "1",

doi = "10.1038/s41467-021-25285-0",

language = "English (US)",

volume = "12",

journal = "Nature communications",

issn = "2041-1723",

publisher = "Nature Research",

number = "1",

}

Ribas, A, Algazi, A, Ascierto, PA, Butler, MO, Chandra, S, Gordon, M, Hernandez-Aya, L, Lawrence, D, Lutzky, J, Miller, WH, Campbell, KM, Delafont, B, Marshall, S, Mueller, N & Robert, C 2021, 'Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma (Nature Communications, (2020), 11, 1, (6262), 10.1038/s41467-020-19810-w)', Nature communications, vol. 12, no. 1, 5022. https://doi.org/10.1038/s41467-021-25285-0

Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma (Nature Communications, (2020), 11, 1, (6262), 10.1038/s41467-020-19810-w). / Ribas, Antoni; Algazi, Alain; Ascierto, Paolo A. et al.
In: Nature communications, Vol. 12, No. 1, 5022, 01.12.2021.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Author Correction

T2 - PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma (Nature Communications, (2020), 11, 1, (6262), 10.1038/s41467-020-19810-w)

AU - Ribas, Antoni

AU - Algazi, Alain

AU - Ascierto, Paolo A.

AU - Butler, Marcus O.

AU - Chandra, Sunandana

AU - Gordon, Michael

AU - Hernandez-Aya, Leonel

AU - Lawrence, Donald

AU - Lutzky, Jose

AU - Miller, Wilson H.

AU - Campbell, Katie M.

AU - Delafont, Bruno

AU - Marshall, Shannon

AU - Mueller, Nancy

AU - Robert, Caroline

PY - 2021/12/1

Y1 - 2021/12/1

N2 - There was an error in the original version of this Article. A table describing the patient characteristics and the sample collection was not included in the paper. This table is now included as Supplementary Data 1 and the first sentence of the Results section has been amended to state ‘Between December 2013 and April 2015, 99 patients were screened. Sixty-eight patients were enrolled from 11 study centers (Supplementary Fig. 1, Supplementary Data 1), with 31 patients subsequently excluded due to screening failures’. The PDF and HTML versions of the Article have been updated.

AB - There was an error in the original version of this Article. A table describing the patient characteristics and the sample collection was not included in the paper. This table is now included as Supplementary Data 1 and the first sentence of the Results section has been amended to state ‘Between December 2013 and April 2015, 99 patients were screened. Sixty-eight patients were enrolled from 11 study centers (Supplementary Fig. 1, Supplementary Data 1), with 31 patients subsequently excluded due to screening failures’. The PDF and HTML versions of the Article have been updated.

UR - http://www.scopus.com/inward/record.url?scp=85112731032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85112731032&partnerID=8YFLogxK

U2 - 10.1038/s41467-021-25285-0

DO - 10.1038/s41467-021-25285-0

M3 - Comment/debate

C2 - 34385448

AN - SCOPUS:85112731032

SN - 2041-1723

VL - 12

JO - Nature communications

JF - Nature communications

IS - 1

M1 - 5022

ER -

Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma (Nature Communications, (2020), 11, 1, (6262), 10.1038/s41467-020-19810-w)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this